Grants for Public housing authorities - Health

This funding opportunity announcement (FOA) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination; (2) promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally; (3) creating, providing, and disseminating innovative research programs and partnerships across institutions and communities to address health disparities and deliver the benefits of translational science to all; (4) creating and implementing scientific and operational innovations that increase the quality, safety, efficiency, effectiveness, and informativeness of clinical research; (5) providing a national resource for the rapid response to urgent public health needs; and (6) creating, providing, and disseminating CTS training for clinical research professionals of all disciplines on the research team. Along with this solicitation for the UM1 CTSA hub application, NCATS has published a separate, companion FOA that solicits applications for a required K12 Clinical Scientist Institutional Career Development Program Award (PAR-TR-22-career); both a UM1 hub application and the required K12 application must be submitted. If there is no companion K12 application submitted, the UM1 hub application will not be reviewed. However, if the UM1 application is funded and the companion K12 application is not funded, a resubmitted K12 application will be accepted. Additional companion FOAs solicit applications for optional training, career, and research ed

This funding opportunity supports organizations in the southern United States to create integrated care models that improve HIV treatment and essential support services for women living with HIV.

This funding opportunity supports research projects aimed at reducing disparities in maternal health outcomes among vulnerable populations in the U.S. by investigating healthcare system and clinician factors.

This grant provides funding to organizations that promote vaccine confidence and health equity through partnerships and educational outreach, particularly targeting underserved populations across the United States.

This funding opportunity supports research institutions and organizations in developing innovative HIV vaccine candidates through preclinical and manufacturing processes, with a focus on partnerships and readiness for clinical trials.

This grant provides funding to support postdoctoral researchers from underrepresented backgrounds in neuroscience as they transition to independent faculty positions, promoting diversity in the field.

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

The "E-Learning Collaborative for Integrated Violence Prevention" grant aims to fund the development and maintenance of an online learning community and platform, which will provide resources, technical assistance, and support to violence prevention practitioners, helping them to effectively implement and evaluate strategies to prevent various types of violence, while also promoting health equity.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development intends to publish a Notice of Funding Opportunity (NOFO) to invite applications to establish integrated and collaborative Stillbirth Research Centers, as part of a new Stillbirth Research Consortium. The Centers will support cutting-edge basic, translational, clinical, and/or data sciences research and generate knowledge to fuel advancement of stillbirth-relevant research in the United States, with a particular emphasis on approaches that utilize an equity lens to identify ways to decrease the incidence of stillbirth in vulnerable populations. A Data Coordinating Center (described in the companion announcement NOT-HD-24-010) will support the work of the research projects funded under the Stillbirth Research Consortium. This Notice is being provided to allow potential applicants additional time to develop meaningful collaborations, interdisciplinary teams, and responsive applications. International collaboration is encouraged and allowable. The NOFO is expected to be published in Summer 2024 with an expected application due date in Winter 2024. This NOFO will utilize the UG1 activity code. Details of the planned NOFO are provided below.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

This funding opportunity supports researchers conducting mid-phase clinical trials on natural products, such as botanicals and dietary supplements, to determine optimal dosages and identify patient responses for future studies.

This grant provides funding for innovative early-stage cancer research projects that could lead to significant advancements in diagnosis, treatment, and prevention, targeting a wide range of eligible organizations including universities, nonprofits, and small businesses.

This funding opportunity provides up to $1 million to research centers focused on improving the diagnosis, treatment, and prevention of intellectual and developmental disabilities through collaborative and innovative research.

This funding opportunity supports research institutions and organizations in developing therapies and medical devices for various eye diseases, facilitating their transition from laboratory to clinical application.

This R21 funding opportunity encourages projects that test, in animals and/or humans, whether modifying electrophysiological patterns can improve cognitive, affective, or social processing. This R21 has a companion R01 (TEMP-10327). The proximal goal of this FOA (and its companion R01) is to encourage investigators to test whether modifying specific patterns of coordinated neural activity in vivo can improve cognitive, social, or affective processes. These studies should be based on a rational understanding of the role of specific neural activity rhythms in, for example, the routing of information among brain regions or in improving the ability of afferent information to affect local processing via coherence of underlying oscillatory activity.

This funding opportunity supports institutions conducting clinical trials focused on improving dental, oral, and craniofacial health by allowing them to extend or revise ongoing studies to gather more data or address new research needs.

This grant provides funding to local organizations in Eswatini to improve and integrate HIV and TB prevention and treatment services, enhancing the capacity of health institutions and ensuring community involvement in the process.

This funding opportunity supports institutions in creating collaborative training networks for early-career researchers focused on advancing studies in kidney, urologic, and hematologic diseases.

This Funding Opportunity Announcement (FOA) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health disparities. These research project grants will support innovative studies designed to investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention strategies, (2) the development and testing of new methodologies and models, and (3) secondary data analyses. This FOA is also designed to aid and facilitate the growth of a nationwide cohort of scientists with a high level of basic research expertise in cancer health disparities research who can expand available resources and tools, such as biospecimens, patient derived models, and methods that are necessary to conduct basic research in cancer health disparities.

This funding opportunity supports researchers exploring the causes and effects of mood and psychotic disorders during menopause, aiming to improve mental health interventions for women experiencing this transition.